The authors were funded by NIH grants 1R01CA122728-01A4 and CA154460-01A1. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial ...
News Medical on MSN3mon
The threat of serous uterine cancer: A new perspectiveMost uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an ...
European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...
GSK plc (LSE/NYSE: GSK) today announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...
Expert Rev Anticancer Ther. 2012;12(1):41-49. © 2012 Expert Reviews Ltd. Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer. USC is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback